Aurora Cannabis (ACB) Liabilities and Shareholders Equity (2018 - 2026)

Aurora Cannabis (ACB) has reported Liabilities and Shareholders Equity for 9 consecutive years, with $438.3 million the latest figure, recorded in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 26.24% year-over-year to $438.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 billion (down 11.04% YoY) and the FY2026 annual result came in at $435.0 million, down 29.09% from the prior year.
• Liabilities and Shareholders Equity retreated to $438.3 million in Q1 2026 per ACB's latest filing, from $556.0 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for ACB reached as high as $1.2 billion in Q1 2022 and fell as low as $438.3 million in Q1 2026.
• A 5-year average of $673.2 million and a median of $612.2 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity plunged 61.75% — and 2024, when it grew 2.84%.
• Year by year, Liabilities and Shareholders Equity stood at $754.3 million in 2022, then decreased by 20.42% to $600.2 million in 2023, then grew by 2.84% to $617.3 million in 2024, then decreased by 9.93% to $556.0 million in 2025, then declined by 21.16% to $438.3 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $438.3 million, $556.0 million, and $550.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.